We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-3.25%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$6.01B
AUM Growth
+$262M
Cap. Flow
-$162M
Cap. Flow %
-2.7%
Top 10 Hldgs %
51.52%
Holding
592
New
224
Increased
125
Reduced
42
Closed
159

Top Buys

Rank Stock Value
1
WAY
Waystar Holding Corp
WAY
+$107M
2
GILD icon
Gilead Sciences
GILD
+$99.5M
3
CVS icon
CVS Health
CVS
+$61M
4
BAX icon
Baxter International
BAX
+$57.9M
5
CGEM icon
Cullinan Oncology
CGEM
+$45.6M

Top Sells

Rank Stock Value
1
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
+$136M
2
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$80.7M
3
SWTX
SpringWorks Therapeutics
SWTX
+$63.2M
4
OSCR icon
Oscar Health
OSCR
+$44.4M
5
VKTX icon
Viking Therapeutics
VKTX
+$38M

Sector Composition

Rank Sector Weight
1 Healthcare 83.29%
2 Industrials 0.69%
3 Technology 0.57%
4 Financials 0.44%
5 Consumer Discretionary 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OTIS icon
326
Otis Worldwide
OTIS
$27.9B
$313K 0.01%
+3,248
New +$313K
MLAB icon
327
Mesa Laboratories
MLAB
$540M
$311K 0.01%
+3,581
New +$375K
BRZE icon
328
Braze
BRZE
$2.65B
$311K 0.01%
+7,995
New +$319K
TRN icon
329
Trinity Industries
TRN
$2.95B
$310K 0.01%
10,376
+1,047
+11% +$30.5K
EXTR icon
330
Extreme Networks
EXTR
$3.92B
$310K 0.01%
+23,026
New +$265K
AEO icon
331
American Eagle Outfitters
AEO
$2.98B
$306K 0.01%
15,316
+3,460
+29% +$79.1K
RLAY icon
332
Relay Therapeutics
RLAY
$4.06B
$304K 0.01%
+46,702
New +$319K
MOH icon
333
Molina Healthcare
MOH
$10.4B
$303K 0.01%
+1,020
New +$346K
LUNG icon
334
Pulmonx
LUNG
$51.5M
$301K 0.01%
47,539
+27,250
+134% +$210K
LENZ
335
LENZ Therapeutics
LENZ
$179M
$300K 0.01%
+17,353
New +$303K
LMT icon
336
Lockheed Martin
LMT
$134B
$300K 0.01%
+642
New +$297K
OPCH icon
337
Option Care Health
OPCH
$3.42B
$300K 0.01%
+10,816
New +$322K
FFIV icon
338
F5
FFIV
$23B
$296K ﹤0.01%
+1,720
New +$301K
FOLD
339
DELISTED
Amicus Therapeutics
FOLD
$295K ﹤0.01%
29,752
+13,263
+80% +$136K
KRYS icon
340
Krystal Biotech
KRYS
$10.4B
$295K ﹤0.01%
+1,605
New +$269K
FR icon
341
First Industrial Realty Trust
FR
$8.81B
$292K ﹤0.01%
+6,152
New +$295K
WWD icon
342
Woodward
WWD
$25B
$287K ﹤0.01%
1,648
+185
+13% +$31.5K
MRCY icon
343
Mercury Systems
MRCY
$6.23B
$285K ﹤0.01%
+10,569
New +$308K
KMX icon
344
CarMax
KMX
$8.29B
$285K ﹤0.01%
3,881
+1,474
+61% +$106K
QTRX icon
345
Quanterix
QTRX
$173M
$284K ﹤0.01%
+21,461
New +$359K
PTON icon
346
Peloton Interactive
PTON
$2.71B
$281K ﹤0.01%
+83,256
New +$298K
WCN
347
Waste Connections
WCN
$42.7B
$281K ﹤0.01%
+1,603
New +$268K
ADUS icon
348
Addus HomeCare
ADUS
$2.16B
$279K ﹤0.01%
+2,407
New +$258K
AKRO
349
DELISTED
Akero Therapeutics
AKRO
$278K ﹤0.01%
11,867
-1,778
-13% -$38K
CPAY icon
350
Corpay
CPAY
$24.8B
$277K ﹤0.01%
+1,039
New +$294K
12 13
14
15 16

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q2 2024 Portfolio in Review

As of Q2 2024, Deerfield Management held 592 positions worth $6.01B, up 4.6% from $5.75B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Deerfield Management's Q2 2024 filing shows 224 new, 125 increased, 42 reduced and 159 closed positions. Its largest new stake was Waystar Holding Corp: 4,952,004 shares worth $106M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $136M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 89% a quarter earlier, followed by Industrials and Technology.

  • Deerfield Management's largest Q2 2024 buy was Waystar Holding Corp: 4,952,004 shares worth $106M.
  • Deerfield Management added most to Baxter International in Q2 2024, an estimated $57.9M increase.
  • Deerfield Management's biggest Q2 2024 reduction was Oscar Health, cutting an estimated $44.4M.
  • Deerfield Management fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $136M.
  • Deerfield Management's ten largest holdings make up 52% of its $6.01B portfolio in Q2 2024.
  • Deerfield Management opened 224 new positions and closed 159 in Q2 2024.
  • Deerfield Management's portfolio value rose 4.6% quarter-over-quarter to $6.01B.

Based on Deerfield Management's 13F filing for Q2 2024, filed 14 Aug 2024.